Global Medical Biomimetics

Medical Biomimetics Comprehensive Study by Type (Cardiovascular, Orthopedic (Prostheses, Exoskeleton), Ophthalmology, Dental, Others), Application (Wound Healing, Tissue Engineering, Drug Delivery, Plastic Surgery, Others) Players and Region - Global Market Outlook to 2028

Medical Biomimetics Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Medical Biomimetics Market?

Medical biomimetics is a creative form of technology that uses or substantially mimics nature in a bid to improve the lives of humans. Some examples of medical biomimetics are shark skin structure-motivated invention of swimsuits with features such as fluid-drag reduction, airplane wings modeled on the wings of birds, and turban shells inspired by robust building structures. The field of medical biomimetics offers many practical applications. Over the past few years, the prospects of the use of medical biomimetics in making surgical instruments have increased. These biomimetically inspired surgical instruments are provided with the functionalities of basic functions performed by the mouth, hands, or feet, such as cutting, sucking, stinging, and gripping.

Highlights from Medical Biomimetics Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAbbott Laboratories (United States), Avinent Science and Technology (Spain), Applied Biomimetic (United States), Blatchford Ltd. (United Kingdom), Biomimetic Solutions (United Kingdom), Hstar Technologies Corporation (United States), BioHorizons IPH, Inc. (United States), Forschungszentrum Jülich (Germany), Biomimetics Technologies (Canada) and Keystone Dental Inc. (United States)


Key players in the Medical Biomimetics market include Veryan Medical, SynTouch Inc., Blatchford Ltd., Skyland Brand Ventures, Avinent Science and Technology, Applied Biomimetic, Biomimetic Solutions, CellCore, and Forschungszentrum Jülich. The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European and United States Players will contribute to the maximum growth of Global Medical Biomimetics market throughout the forecasted period.

Abbott Laboratories (United States), Avinent Science and Technology (Spain), Applied Biomimetic (United States), Blatchford Ltd. (United Kingdom), Biomimetic Solutions (United Kingdom), Hstar Technologies Corporation (United States), BioHorizons IPH, Inc. (United States), Forschungszentrum Jülich (Germany), Biomimetics Technologies (Canada) and Keystone Dental Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are CellCore (Nigeria), BioTomo (Brazil), Skyland Brand Ventures (United States), Veryan Medical (United Kingdom) and SynTouch LLC (United States).

Medical Biomimetics Market Segmentation:
ScopeSub-Segments
Application / End UserWound Healing, Tissue Engineering, Drug Delivery, Plastic Surgery and Others
TypeCardiovascular, Orthopedic (Prostheses, Exoskeleton), Ophthalmology, Dental and Others


On the basis of geography, the market of Medical Biomimetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Tissue Engineering Applications

Market Growth Drivers:
Growing Elderly Population and Increasing Rate of Organ Failure, Favorable Funding Scenario and Increase in the Adoption of Biomimetic Technology for Organ Regeneration

Challenges:
High Per Unit Production Cost Related to Low Volume of Sales

Restraints:
Stringent Clinical and Regulatory Requirements

Opportunities:
Increase in Research and Development Activities, and Advancements in Nanotechnology and Rise in Demand for Biomimetics for Various Medical Applications

Key Target Audience
Medical Biomimetics Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

Market Leaders & Development Strategies
In September 2021, Keystone Dental Inc. the largest independent dental implant company announced the acquisition of Osteon Medical, a technology company based in Melbourne and Australia that leverages proprietary software and proprietary hardware development to deliver digital solutions to clinicians and dental laboratories to dramatically improve digital workflows. This increases Keystone's global recognition in the dental market with its innovative solutions and quality products.
In September 2020, Veryan Medical announces the launch of its revolutionary BioMimics 3D Vascular Stent System. The BioMimics 3D Vascular Stent System is designed to improve lumen diameter when treating symptomatic de novo or restenotic lesions in the native superficial femoral and proximal popliteal arteries.


Report Objectives / Segmentation Covered

By Type
  • Cardiovascular
  • Orthopedic (Prostheses, Exoskeleton)
  • Ophthalmology
  • Dental
  • Others
By Application
  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Plastic Surgery
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Elderly Population and Increasing Rate of Organ Failure
      • 3.2.2. Favorable Funding Scenario
      • 3.2.3. Increase in the Adoption of Biomimetic Technology for Organ Regeneration
    • 3.3. Market Challenges
      • 3.3.1. High Per Unit Production Cost Related to Low Volume of Sales
    • 3.4. Market Trends
      • 3.4.1. Rising Tissue Engineering Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medical Biomimetics, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Medical Biomimetics (Value)
      • 5.2.1. Global Medical Biomimetics by: Type (Value)
        • 5.2.1.1. Cardiovascular
        • 5.2.1.2. Orthopedic (Prostheses, Exoskeleton)
        • 5.2.1.3. Ophthalmology
        • 5.2.1.4. Dental
        • 5.2.1.5. Others
      • 5.2.2. Global Medical Biomimetics by: Application (Value)
        • 5.2.2.1. Wound Healing
        • 5.2.2.2. Tissue Engineering
        • 5.2.2.3. Drug Delivery
        • 5.2.2.4. Plastic Surgery
        • 5.2.2.5. Others
      • 5.2.3. Global Medical Biomimetics Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Medical Biomimetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Avinent Science and Technology (Spain)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Applied Biomimetic (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Blatchford Ltd. (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biomimetic Solutions (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hstar Technologies Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioHorizons IPH, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Forschungszentrum Jülich (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Biomimetics Technologies (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Keystone Dental Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Medical Biomimetics Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Medical Biomimetics (Value)
      • 7.2.1. Global Medical Biomimetics by: Type (Value)
        • 7.2.1.1. Cardiovascular
        • 7.2.1.2. Orthopedic (Prostheses, Exoskeleton)
        • 7.2.1.3. Ophthalmology
        • 7.2.1.4. Dental
        • 7.2.1.5. Others
      • 7.2.2. Global Medical Biomimetics by: Application (Value)
        • 7.2.2.1. Wound Healing
        • 7.2.2.2. Tissue Engineering
        • 7.2.2.3. Drug Delivery
        • 7.2.2.4. Plastic Surgery
        • 7.2.2.5. Others
      • 7.2.3. Global Medical Biomimetics Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medical Biomimetics: by Type(USD Million)
  • Table 2. Medical Biomimetics Cardiovascular , by Region USD Million (2017-2022)
  • Table 3. Medical Biomimetics Orthopedic (Prostheses, Exoskeleton) , by Region USD Million (2017-2022)
  • Table 4. Medical Biomimetics Ophthalmology , by Region USD Million (2017-2022)
  • Table 5. Medical Biomimetics Dental , by Region USD Million (2017-2022)
  • Table 6. Medical Biomimetics Others , by Region USD Million (2017-2022)
  • Table 7. Medical Biomimetics: by Application(USD Million)
  • Table 8. Medical Biomimetics Wound Healing , by Region USD Million (2017-2022)
  • Table 9. Medical Biomimetics Tissue Engineering , by Region USD Million (2017-2022)
  • Table 10. Medical Biomimetics Drug Delivery , by Region USD Million (2017-2022)
  • Table 11. Medical Biomimetics Plastic Surgery , by Region USD Million (2017-2022)
  • Table 12. Medical Biomimetics Others , by Region USD Million (2017-2022)
  • Table 13. South America Medical Biomimetics, by Country USD Million (2017-2022)
  • Table 14. South America Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 15. South America Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 16. Brazil Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 17. Brazil Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 18. Argentina Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 19. Argentina Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 20. Rest of South America Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 21. Rest of South America Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 22. Asia Pacific Medical Biomimetics, by Country USD Million (2017-2022)
  • Table 23. Asia Pacific Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 24. Asia Pacific Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 25. China Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 26. China Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 27. Japan Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 28. Japan Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 29. India Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 30. India Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 31. South Korea Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 32. South Korea Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 33. Taiwan Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 34. Taiwan Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 35. Australia Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 36. Australia Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 37. Rest of Asia-Pacific Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 38. Rest of Asia-Pacific Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 39. Europe Medical Biomimetics, by Country USD Million (2017-2022)
  • Table 40. Europe Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 41. Europe Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 42. Germany Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 43. Germany Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 44. France Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 45. France Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 46. Italy Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 47. Italy Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 48. United Kingdom Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 49. United Kingdom Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 50. Netherlands Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 51. Netherlands Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 52. Rest of Europe Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 53. Rest of Europe Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 54. MEA Medical Biomimetics, by Country USD Million (2017-2022)
  • Table 55. MEA Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 56. MEA Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 57. Middle East Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 58. Middle East Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 59. Africa Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 60. Africa Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 61. North America Medical Biomimetics, by Country USD Million (2017-2022)
  • Table 62. North America Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 63. North America Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 64. United States Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 65. United States Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 66. Canada Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 67. Canada Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 68. Mexico Medical Biomimetics, by Type USD Million (2017-2022)
  • Table 69. Mexico Medical Biomimetics, by Application USD Million (2017-2022)
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Medical Biomimetics: by Type(USD Million)
  • Table 81. Medical Biomimetics Cardiovascular , by Region USD Million (2023-2028)
  • Table 82. Medical Biomimetics Orthopedic (Prostheses, Exoskeleton) , by Region USD Million (2023-2028)
  • Table 83. Medical Biomimetics Ophthalmology , by Region USD Million (2023-2028)
  • Table 84. Medical Biomimetics Dental , by Region USD Million (2023-2028)
  • Table 85. Medical Biomimetics Others , by Region USD Million (2023-2028)
  • Table 86. Medical Biomimetics: by Application(USD Million)
  • Table 87. Medical Biomimetics Wound Healing , by Region USD Million (2023-2028)
  • Table 88. Medical Biomimetics Tissue Engineering , by Region USD Million (2023-2028)
  • Table 89. Medical Biomimetics Drug Delivery , by Region USD Million (2023-2028)
  • Table 90. Medical Biomimetics Plastic Surgery , by Region USD Million (2023-2028)
  • Table 91. Medical Biomimetics Others , by Region USD Million (2023-2028)
  • Table 92. South America Medical Biomimetics, by Country USD Million (2023-2028)
  • Table 93. South America Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 94. South America Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 95. Brazil Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 96. Brazil Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 97. Argentina Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 98. Argentina Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 99. Rest of South America Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 100. Rest of South America Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 101. Asia Pacific Medical Biomimetics, by Country USD Million (2023-2028)
  • Table 102. Asia Pacific Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 103. Asia Pacific Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 104. China Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 105. China Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 106. Japan Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 107. Japan Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 108. India Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 109. India Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 110. South Korea Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 111. South Korea Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 112. Taiwan Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 113. Taiwan Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 114. Australia Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 115. Australia Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 116. Rest of Asia-Pacific Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 117. Rest of Asia-Pacific Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 118. Europe Medical Biomimetics, by Country USD Million (2023-2028)
  • Table 119. Europe Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 120. Europe Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 121. Germany Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 122. Germany Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 123. France Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 124. France Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 125. Italy Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 126. Italy Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 127. United Kingdom Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 128. United Kingdom Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 129. Netherlands Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 130. Netherlands Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 131. Rest of Europe Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 132. Rest of Europe Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 133. MEA Medical Biomimetics, by Country USD Million (2023-2028)
  • Table 134. MEA Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 135. MEA Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 136. Middle East Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 137. Middle East Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 138. Africa Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 139. Africa Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 140. North America Medical Biomimetics, by Country USD Million (2023-2028)
  • Table 141. North America Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 142. North America Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 143. United States Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 144. United States Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 145. Canada Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 146. Canada Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 147. Mexico Medical Biomimetics, by Type USD Million (2023-2028)
  • Table 148. Mexico Medical Biomimetics, by Application USD Million (2023-2028)
  • Table 149. Research Programs/Design for This Report
  • Table 150. Key Data Information from Secondary Sources
  • Table 151. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Biomimetics: by Type USD Million (2017-2022)
  • Figure 5. Global Medical Biomimetics: by Application USD Million (2017-2022)
  • Figure 6. South America Medical Biomimetics Share (%), by Country
  • Figure 7. Asia Pacific Medical Biomimetics Share (%), by Country
  • Figure 8. Europe Medical Biomimetics Share (%), by Country
  • Figure 9. MEA Medical Biomimetics Share (%), by Country
  • Figure 10. North America Medical Biomimetics Share (%), by Country
  • Figure 11. Global Medical Biomimetics share by Players 2022 (%)
  • Figure 12. Global Medical Biomimetics share by Players (Top 3) 2022(%)
  • Figure 13. Global Medical Biomimetics share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 17. Avinent Science and Technology (Spain) Revenue, Net Income and Gross profit
  • Figure 18. Avinent Science and Technology (Spain) Revenue: by Geography 2022
  • Figure 19. Applied Biomimetic (United States) Revenue, Net Income and Gross profit
  • Figure 20. Applied Biomimetic (United States) Revenue: by Geography 2022
  • Figure 21. Blatchford Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Blatchford Ltd. (United Kingdom) Revenue: by Geography 2022
  • Figure 23. Biomimetic Solutions (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Biomimetic Solutions (United Kingdom) Revenue: by Geography 2022
  • Figure 25. Hstar Technologies Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Hstar Technologies Corporation (United States) Revenue: by Geography 2022
  • Figure 27. BioHorizons IPH, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. BioHorizons IPH, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Forschungszentrum Jülich (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Forschungszentrum Jülich (Germany) Revenue: by Geography 2022
  • Figure 31. Biomimetics Technologies (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Biomimetics Technologies (Canada) Revenue: by Geography 2022
  • Figure 33. Keystone Dental Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Keystone Dental Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Global Medical Biomimetics: by Type USD Million (2023-2028)
  • Figure 36. Global Medical Biomimetics: by Application USD Million (2023-2028)
  • Figure 37. South America Medical Biomimetics Share (%), by Country
  • Figure 38. Asia Pacific Medical Biomimetics Share (%), by Country
  • Figure 39. Europe Medical Biomimetics Share (%), by Country
  • Figure 40. MEA Medical Biomimetics Share (%), by Country
  • Figure 41. North America Medical Biomimetics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Avinent Science and Technology (Spain)
  • Applied Biomimetic (United States)
  • Blatchford Ltd. (United Kingdom)
  • Biomimetic Solutions (United Kingdom)
  • Hstar Technologies Corporation (United States)
  • BioHorizons IPH, Inc. (United States)
  • Forschungszentrum Jülich (Germany)
  • Biomimetics Technologies (Canada)
  • Keystone Dental Inc. (United States)
Additional players considered in the study are as follows:
CellCore (Nigeria) , BioTomo (Brazil) , Skyland Brand Ventures (United States) , Veryan Medical (United Kingdom) , SynTouch LLC (United States)
Select User Access Type

Key Highlights of Report


May 2023 233 Pages 55 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medical Biomimetics Quantitative research analysis
Global Medical Biomimetics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Elderly Population and Increasing Rate of Organ Failure " is seen as one of major growth factors of Medical Biomimetics Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Medical Biomimetics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Medical Biomimetics Report?

Have a Query? Click Here

Other Related Reports

Antimicrobial Susceptibility Testing Comprehensive Study by Type (Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility T...
$ 3750
Peptides Comprehensive Study by Type (Custom (Standard , Quant , Cyclic Custom , Others), Catalog (Neuroscience, Cardiovascular, Diabetes, Others)), Application (Commercial, Academic Research, Therap...
$ 3450
DNA and Gene Chip Comprehensive Study by Type (Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}, CDNA Chips {Mechanical M...
$ 3750
Extremity Tissue Expander Comprehensive Study by Type (Upper extremities, Lower extremities), Application (Breast reconstruction, Scalp reconstruction, Oral and maxillofacial reconstruction, Paediatr...
$ 3650
Antibiotic Resistance Comprehensive Study by Disease (Complicated Urinary Tract Infection {cUTI}, Complicated Intra-Abdominal Infections {cIAI}, Blood Stream Infections {BSI}, Clostridium difficile i...
$ 3750
BioPharma Buffers Comprehensive Study by Type (Phosphates, Acetates, TRIS, Others), Application (Research Institution, Pharmaceutical Industry, Others), Distribution Channel (Online, Offline), Packag...
$ 3450